ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IBO vs GRDX // OPERATING MARGIN

Impact BioMedical Inc. (NYSE) VS. GridAI Technologies Corp. (NASDAQ) • 15-METRIC TALLY: IBO 2 — GRDX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IBO VS. GRDX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IBO GRDX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% -30.00% 0.00 TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.50% -20.00% -7.50 GRDX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.72% -14.67% +8.95 IBO /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.88 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.2 50.7 -3.50 GRDX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $34.3M $34.2M $102.1K IBO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IBO REV GRDX REV IBO GROSS % GRDX GROSS % IBO FCF GRDX FCF
FY 2025 $32.0K $36.3K -50.0% -50.0% -$1.9M -$5.7M
FY 2024 $80.5M $43.7M — — -$2.9M -$9.2M
FY 2023 $11.3M $44.2M — — -$2.9M -$12.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IBO // BETA —
GRDX // BETA —